Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 116 days ( 0 % )
Last Price $4.50 0 %
High/ Low $4.50 - $4.50 0%
Chg 7 Days N/A $4.50 $4.50
Chg 30 Days N/A $4.50 $4.50
Chg 12 mos -31.92 % $6.61 $4.50
Trend - 3 mos N/A Width: 0 %
Trend - 12 mos -44.52 % Width: 77.41 %
Pred. range - 3 mos N/A - N/A -100.00 % - -100.00 %
Pred. range - 12 mos $1.50 - $2.66 -66.65 % - -40.84 %
Short MA avg 3 mos Sell Nov 30, -1 - N/A days
Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short/Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short MA avg 12 mos Buy Feb 09, 2022 - 131 days
Long MA avg 12 mos Buy Nov 08, 2021 - 195 days
Short/Long MA avg 12 mos Sell Nov 30, -1 - N/A days
Pivot Short Buy Aug 16, 2022 - 2 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Proteon Therapeutics

Proteon Therapeutics Proteon Therapeutics, Inc., a late-stage biopharmaceutical company, focuses on the development of pharmaceuticals to address the needs of patients with renal and vascular diseases. It develops vonapanitase, a recombinant human elastase, which is in two Phase III clinical trials in patients with chronic kidney disease undergoing surgical creation of a radiocephalic arteriovenous fistula for hemodialysis; has completed a Phase I/II clinical trials ... PRTO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT